Intra-Cellular Therapies, Inc.
ITCI · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $307 | $464 | $695 | $142 |
| Short-Term Investments | $694 | $542 | $330 | $336 |
| Receivables | $167 | $146 | $146 | $131 |
| Inventory | $26 | $24 | $20 | $16 |
| Other Curr. Assets | $114 | $96 | $76 | $68 |
| Total Curr. Assets | $1,307 | $1,272 | $1,264 | $691 |
| Property Plant & Equip (Net) | $15 | $16 | $16 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $45 | $37 | $40 | $43 |
| Total NC Assets | $60 | $53 | $56 | $57 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,367 | $1,324 | $1,321 | $747 |
| Liabilities | – | – | – | – |
| Payables | $26 | $10 | $18 | $12 |
| Short-Term Debt | $4 | $8 | $8 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $175 | $147 | $136 | $120 |
| Total Curr. Liab. | $206 | $166 | $162 | $135 |
| LT Debt | $13 | $14 | $14 | $13 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $13 | $14 | $14 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $17 | $18 | $18 | $16 |
| Total Liabilities | $218 | $180 | $176 | $148 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,692 | -$1,675 | -$1,649 | -$1,632 |
| AOCI | $0 | $2 | -$1 | -$0 |
| Other Equity | $2,840 | $2,818 | $2,794 | $2,232 |
| Total Equity | $1,148 | $1,145 | $1,145 | $599 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,367 | $1,324 | $1,321 | $747 |
| Net Debt | -$290 | -$442 | -$673 | -$125 |